Saiko-ka-ryukotsu-borei-to, an herbal medicine, prevents chronic stress-induced disruption of glucocorticoid negative feedback in rats

Life Sciences

Volumn 72, Issue 1, 2002, Pages 67-77

  Mizoguchi, Kazushige ^a   Yuzurihara, Mitsutoshi ^a   Ishige, Atsushi ^a   Sasaki, Hiroshi ^a   Tabira, Takeshi ^b  

^a TSUMURA AND CO   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Chronic stress; Corticosterone; Depression; Dexamethasone suppression test; Glucocorticoid negative feedback; Herbal (kampo) medicine; Rat; Saiko ka ryukotsu borei to

Indexed keywords

CORTICOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; HERBACEOUS AGENT; SAIKO KA RYUKOTSU BOREI TO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HYPOPHYSIS ADRENAL SYSTEM; MALE; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NONHUMAN; ORGAN WEIGHT; RAT; RELAPSE; STRESS; WATER IMMERSION;

ADRENAL GLANDS; ANIMALS; ANTIDEPRESSIVE AGENTS; BODY WEIGHT; CHRONIC DISEASE; CORTICOSTERONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUGS, CHINESE HERBAL; GLUCOCORTICOIDS; ORGAN SIZE; RATS; RATS, WISTAR; STRESS;

EID: 0037159569     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02199-9     Document Type: Article

References (33)

1. Mazure C.M. Does stress cause psychiatric illness? Spiegel D. Progress in Psychiatry. 1995;270-280 American Psychiatric Press, Washington DC.
2. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., James N.M., Kronfol Z., Lohr N., Steiner M., de Vigne J.P., Young E. A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility. Archives of General Psychiatry. 38(1):1981;15-22.
3. Kalin N.H., Weiler S.J., Shelton S.E. Plasma ACTH and cortisol concentration before and after dexamethasone. Psychiatry Research. 7(1):1982;87-92.
4. Holsboer F. The dexamethasone suppression test in depressed patients: Clinical and biochemical aspects. Journal of Steroid Biochemistry. 19(1A):1983;251-257.
5. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Archives of General Psychiatry. 42(12):1985;1193-1204.
6. Rubin R.T., Phillips J.J., Sadow T.F., McCracken J.T. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Archives of General Psychiatry. 52(3):1995;213-218.
7. Haracz J.L., Minor T.R., Wilkins J.N., Zimmermann E.G. Learned helplessness: an experimental model of the DST in rats. Biological Psychiatry. 23(4):1988;388-396.
8. Young E.A., Akana S., Dallman M.F. Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats. Neuroendocrinology. 51(5):1990;536-542.
9. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology. 26:2001;443-459.
10. Yamada K., Kanba S. Kampo therapy and stress in the field of neuropsychiatry. Progress in Medicine. 17:1997;817-822.
11. Sarai K. Oriental medicine as therapy for resistant depression: use of some herbal drugs in the Far East (Japan). Progress in Neuro-Psychopharmacology and Biological Psychiatry. 16(2):1992;171-180.
12. Kanba S., Yamada K., Mizushima H., Asai M. Use of herbal medicine for treating psychiatric disorders in Japan. Psychiatry and Clinical Neuroscience. 52(Supplement):1998;S331-S333.
13. Kikutani T. Treatment of insomnia by ethical kampo drugs, applied to health insurance system. Journal of Traditional Sino-Japanese Medicine. 5:1984;23-27.
14. Iijima O.T., Minematsu S., Maemura S., Waterson L.A., Gopinath C., Connick H. A single oral dose toxicity study and a 13-week repeated dose study with a 4-week recovery period of TSUMURA saiko-ka-ryukotsu-borei-to (TJ-12) in rats. Japanese Pharmacology and Therapeutics. 23(Supplement 95):1995;S1739-S1753.
15. Sasaki K., Suzuki K., Yoshizaki F., Ando T. Effect of saiko-ka-ryukotsu-borei-to on the stress-induced increase of serum corticosterone in mice. Biological and Pharmaceutical Bulletin. 18(4):1995;563-565.
16. Koshikawa N., Imai T., Takahashi I., Yamauchi M., Sawada S., Kansaku A. Effects of hochu-ekki-to, yoku-kan-san and saiko-ka-ryukotsu-borei-to on behavioral despair and acetic acid-induced writhing in mice. Methods and Findings in Experimental and Clinical Pharmacology. 20(1):1998;47-51.
17. Sapolsky R.M., Krey L.C., McEwen B.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proceedings of the National Academy of Sciences USA. 81(19):1984;6174-6177.
18. Iizuka S., Ishige A., Komatsu Y., Matsumiya T., Tsuji M., Takeda H. Effects of saiko-ka-ryukotsu-borei-to on irritable characteristics in El mice. Methods and Findings in Experimental and Clinical Pharmacology. 20(1):1998;19-26.
19. Sasaki K., Suzuki K., Ueno M., Takako K., Yoshizaki F. Increase in monoamine levels caused by emotional stress in mice brain regions is attenuated by saiko-ka-ryukotsu-borei-to. Methods and Findings in Experimental and Clinical Pharmacology. 20(1):1998;27-30.
20. Miller A.H., Spencer R.L., Pulera M., Kang S., McEwen B.S., Stein M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. Biological Psychiatry. 32(10):1992;850-869.
21. Feldman S., Conforti N. Modifications of adrenocortical responses following frontal cortex simulation in rats with hypothalamic deafferentations and medial forebrain bundle lesions. Neuroscience. 15(4):1985;1045-1047.
22. Magarinos A.M., Somoza G., De Nicola A.F. Glucocorticoid negative feedback and glucocorticoid receptors after hippocampectomy in rats. Hormone and Metabolic Research. 19(3):1987;105-109.
23. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. Journal of Neuroscience. 13(9):1993;3839-3847.
24. Feldman S., Weidenfeld J. Glucocorticoid receptor antagonists in the hippocampus modify the negative feedback following neural stimuli. Brain Research. 821(1):1999;33-37.
25. Kovács K.J., Makara G.B. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Research. 474(2):1988;205-210.
26. Hiai S., Yokoyama H., Nagasawa T., Oura H. Stimulation of the pituitary-adrenocortical axis by saikosaponin of Bupleuri radix. Chemical and Pharmaceutical Bulletin. 29(2):1981;495-499.
27. Yokoyama H., Hiai S., Oura H. Chemical structures and corticosterone secretion-inducing activities of saikosaponins. Chemical and Pharmaceutical Bulletin. 29(2):1981;500-504.
28. Hiai S., Sasaki S., Oura H. Effect of ginseng saponin on rat adrenal cyclic AMP. Planta Medica. 37(1):1979;15-19.
29. Lee Y.J., Chung E., Lee K.Y., Lee Y.H., Huh B., Lee S.K. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Molecular and Cellular Endocrinology. 133:1997;135-140.
30. Steckler T., Holsboer F., Reul J.M. Glucocorticoids and depression. Baillières Best Practice and Research in Clinical Endocrinology and Metabolism. 13(4):1999;597-614.
31. Stokes P.E. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharmacology. 5(Supplement):1995;77-82.
32. Charles G.A., Schittecatte M., Rush A.J., Panzer M., Wilmotte J. Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression. Journal of Affective Disorders. 17:1989;271-278.
33. O'Toole S.M., Sekula L.K., Rubin R.T. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biological Psychiatry. 42:1997;85-89.